Available datapackage for study 'A Multicenter Phase 2 Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens'
收藏Mendeley Data2024-01-31 更新2024-06-27 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00009371.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the clinical benefit of subcutaneous (SC) daratumumab administered in combination with standard multiple myeloma (MM) regimens in participants with MM as measured by overall response rate (ORR) or very good partial response (VGPR) or better rate.
创建时间：
2024-01-31
